- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.03. | Novartis to acquire SNV4818 from Synnovation | ||
| 20.03. | Congruence secures $39.5m to advance small molecule correctors pipeline | ||
| 20.03. | J&J wins FDA approval for Icotyde to enter psoriasis pill market | ||
| 19.03. | MHRA and NICE launch aligned pathway for faster medicine regulation | ||
| 19.03. | Quintessence debuts first 'living' artificial cell for CGT bio-separation | ||
| 19.03. | Huntington's gene therapy research has reached a turning point, expert says | ||
| 18.03. | Calls for change as access to cell and gene therapies in the Netherlands falls short | ||
| 18.03. | Excalipoint debuts with $68.7m to progress TCE pipeline | ||
| 18.03. | GSK prepared for potential expansion of meningitis vaccine schedule amid UK outbreak | ||
| 18.03. | Navigating the valley of death: a how-to from an investor's perspective | ||
| 18.03. | R1 Therapeutics raises $77.5m to progress AP306 for hyperphosphatemia | ||
| 18.03. | FDA issues CRL to Aldeyra's reproxalap drug application | ||
| 17.03. | RFK Jr's vaccine overhaul halted by federal judge's ruling | ||
| 17.03. | FDA accepts Sun Pharma's Ilumya sBLA for psoriatic arthritis | ||
| 17.03. | Sentynl and PRG partner for Progerinin licence | ||
| 16.03. | Most London patients go private to access weight loss drugs | ||
| 16.03. | GSK's RSV jab secures FDA label expansion to larger adult population | ||
| 16.03. | Biophytis and LynxKite expand alliance to boost AI-driven drug discovery | ||
| 16.03. | Novartis wins FDA approval for Cosentyx to treat paediatric HS patients | ||
| 13.03. | Parkinson's research reaches "pivotal" stage, but barriers remain | ||
| 13.03. | WHO directs antibiotic development to priority pathogens | ||
| 13.03. | PRISM BioLab partners with Receptor.AI for molecule discovery | ||
| 13.03. | PsiQuantum and National Cancer Center Japan partner on quantum computing | ||
| 12.03. | Vima banks $100m in Series A to progress Parkinson's drug | ||
| 12.03. | Eli Lilly finds impurity in compounded tirzepatide |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.